Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oncolytics Biotech Inc. - Common Shares
(NQ:
ONCY
)
0.9706
+0.0206 (+2.17%)
Streaming Delayed Price
Updated: 11:58 AM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
114,210
Open
0.9700
Bid (Size)
0.9700 (10,900)
Ask (Size)
0.9727 (400)
Prev. Close
0.9500
Today's Range
0.9700 - 0.9999
52wk Range
0.3258 - 1.510
Shares Outstanding
46,166,980
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
Issued on behalf of Oncolytics Biotech Inc.
From
Equity Insider
Via
GlobeNewswire
Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer
December 16, 2025
From
Oncolytics Biotech Inc.
Via
Business Wire
Performance
YTD
+4.4%
+4.4%
1 Month
-5.8%
-5.8%
3 Month
-23.6%
-23.6%
6 Month
+44.0%
+44.0%
1 Year
+7.2%
+7.2%
More News
Read More
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
From
USA News Group
Via
GlobeNewswire
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
December 12, 2025
From
Equity Insider
Via
GlobeNewswire
Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada
December 09, 2025
From
Oncolytics Biotech Inc.
Via
Business Wire
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
December 06, 2025
From
USA News Group
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
December 04, 2025
Via
Chartmill
UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
From
USA News Group
Via
GlobeNewswire
The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
December 03, 2025
From
USA News Group
Via
GlobeNewswire
Oncolytics Biotech® Provides Update on Special Meeting of Shareholders
November 20, 2025
From
Oncolytics Biotech Inc.
Via
Business Wire
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
November 19, 2025
Via
FinancialNewsMedia
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
November 19, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer
November 19, 2025
From
Oncolytics Biotech Inc.
Via
Business Wire
Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy
November 04, 2025
From
Oncolytics Biotech® Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 15, 2025
Via
Benzinga
Earnings Scheduled For August 8, 2025
↗
August 08, 2025
Via
Benzinga
What to Expect from Oncolytics Biotech's Earnings
↗
August 07, 2025
Via
Benzinga
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
July 08, 2025
Via
FinancialNewsMedia
Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
July 08, 2025
Via
FinancialNewsMedia
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
July 08, 2025
From
FN Media Group LLC
Via
GlobeNewswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough
June 26, 2025
Via
FinancialNewsMedia
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
June 24, 2025
Via
FinancialNewsMedia
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
June 18, 2025
Via
FinancialNewsMedia
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
June 11, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Frequently Asked Questions
Is Oncolytics Biotech Inc. - Common Shares publicly traded?
Yes, Oncolytics Biotech Inc. - Common Shares is publicly traded.
What exchange does Oncolytics Biotech Inc. - Common Shares trade on?
Oncolytics Biotech Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Oncolytics Biotech Inc. - Common Shares?
The ticker symbol for Oncolytics Biotech Inc. - Common Shares is ONCY on the Nasdaq Stock Market
What is the current price of Oncolytics Biotech Inc. - Common Shares?
The current price of Oncolytics Biotech Inc. - Common Shares is 0.9706
When was Oncolytics Biotech Inc. - Common Shares last traded?
The last trade of Oncolytics Biotech Inc. - Common Shares was at 12/24/25 11:58 AM ET
What is the market capitalization of Oncolytics Biotech Inc. - Common Shares?
The market capitalization of Oncolytics Biotech Inc. - Common Shares is 44.81M
How many shares of Oncolytics Biotech Inc. - Common Shares are outstanding?
Oncolytics Biotech Inc. - Common Shares has 45M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
